Late-breaking abstract presentation: overall survival by number of prior lines of chemotherapy in patients with brcamutated platinum-sensitive relapsed ovarian cancer receiving olaparib treatment or non-platinum chemotherapy in solo3
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要